Biography. Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Centene Board of Directors. Subscriber only .
Centene Corp (CNC) Q2 2020 Earnings Call Transcript And less than a month ago, Centene said Neidorff was taking a medical leave of absence to address what he called a treatable medical condition, putting several executives including London to work to fill the void left by Neidorffs absence. Before joining Centene in 2020, Ms. London was a Partner at Optum Ventures, the venture capital arm of UnitedHealth Group. "Sarah has infused an innovative mindset across the enterprise in her relentless effort to improve Centene's capabilities to provide the highest quality of care for our members. Chicago/NYC. Since Mr. Neidorff began a medical leave of absence in February 2022, she has been a member of the Office of the Chairman charged with running the day-to-day management of the Company. Glassdoor gives you an inside look at what it's like to work at Centene, including salaries, reviews, office photos, and more. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. is attached hereto as Exhibit 99.1 and incorporated herein by reference. The board of Centene has picked Sarah London an executive with roots in venture capital and talent. Without limiting the foregoing, forward-looking statements often use words such as "believe," "anticipate," "plan," "expect," "estimate," "intend," "seek," "target," "goal," "may," "will," "would," "could," "should," "can," "continue" and other similar words or expressions (and the negative thereof). Prior to her appointment as CEO, Ms. London served as Vice Chairman of the Company, and in her management role was responsible for a portfolio of companies independent of Centene's health plans, designing differentiated platform capabilities, and delivering industry-leading products and services to third-party customers. Together, we can deliver innovative, integrated, and equitable care that meets our members where they live and exceeds their expectations. The company will report its 2022 first quarter earnings on April. Oregon health agency approves Amazon, One Medical acquisition, moving $3.9B deal one step forward. Ken Fasola. The board of Centene has picked Sarah London an executive with roots in venture capital and talent management to succeed Michael Neidorff as the companys CEO.
Sarah M. London is the Pres of Health Care Enterprises & Exec. Kevin Carmichael: Canada's 'blowout' jobs report raises questions about the path of interest rates. ST. LOUIS, March 22, 2022 /PRNewswire/ --Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective immediately, succeeding Michael Neidorff. .
Working at Centene | Glassdoor Sarah London, Chief Executive Officer, Centene, Chief Executive Officer Except as may be otherwise required by law, we undertake no obligation to update or revise the forward-looking statements included in this press release, whether as a result of new information, future events or otherwise, after the date hereof. 1. HealthCare Enterprises is a portfolio of high growth companies independent of Centene health plans, designing differentiated platform capabilities and delivering industry-leading products and . You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to: our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively; uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully; restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission. Centene focuses on long-term growth and value creation as well as the development of its people, systems, and capabilities so that it can better serve its members, providers, local communities, and government partners.
Centene Promotes Tech And Healthcare Strategist Sarah London - Forbes By continuing to use our site, you agree to our Privacy Policy and Terms and Conditions. Women represent 76% of our employees and 65% of employees in supervisory positions. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Previously, she served as Chief Product Officer for Optum Analytics and Vice President of Client Services & Operations at Humedica. Currently, Sarah London works as a Chief Executive Officer at Centene. Since her appointment to lead the company in 2022, she has focused on developing a culture of transformation, implementing artificial intelligence and machine learning solutions to better improve health and quality of life for Centenes members. 48% of all employees identify as people of color, including 36% at the supervisory + level. The Company takes a local approach with local brands and local teams to provide fully integrated, high-quality, and cost-effective services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. New SEC Custody Rule Would Scare Away Qualified Custodians: Lawyer, Why Secure 2.0s RMD Delay Matters Even More Than Many Think, Long COVID Correlates With High Mortality: Health Insurer, Antitrust Suit Challenging Schwab-TD Ameritrade Deal Can Proceed, Judge Rules, When Medicare Enrollees Return to Work: A Medicare Customer Q&A, How to Attract the Best, Most Overlooked Clients, Divorce Looks Like Forced Early Retirement for Many Wealthy Women, Advisor Says, Advisor Speaks Out on Industry's Treatment of Women. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on. Since then, the company has become a major force in the commercial health insurance market by acquiring Health Net, a California health insurer; WellCare Health Plans, a big Medicare plans issuer; and Magellan Health, a behavioral health, specialty care and pharmacy benefits manager. Her focus has been advancing integrated, value-based care models through the development and application of data-driven insights and technology.
Carla Padilla on LinkedIn: Sarah London | 2022 Most Powerful Women Sarah London - Senior Manager, Global Meetings & Events - LinkedIn Centene Centene has promoted Sarah London, the health insurance company's current board vice chair, to the job as Chief Executive Officer, succeeding the retiring Michael Neidorff, the. Centene Salaries trends. From September 2011 to June 2016, he served as the Company's Senior Vice President, Business Development. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. The oldest executive at Centene Corp. is RobertDitmore, 86, who is the Presiding Independent Director. Thorough reviews have been conducted to assure this data accurately reflects disclosures. Neidorff, who is 79 years old and has been Centenes CEO since 1996, also took on a new role as executive chairman until the end of 2022, the company announced in December. Centene Corporation, (d) Election of Sarah London as a Member of the Board, ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL By their nature, forward-looking statements involve known and unknown risks and uncertainties and are subject to change because they relate to events and depend on circumstances that will occur in the future, including economic, regulatory, competitive and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Biography. Centene (the Company, our, or we) intends such forward-looking statements to be covered by the safe-harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe-harbor provisions. Chief Operating Officer.
CENTENE CORP Executive Salaries & Other Compensation | Salary.com On average, Centene executives and independent directors trade stock every 17 days with the average trade being worth of $1,189,041. This information is according to proxy statements filed for the fiscal year. In particular, these statements include, without limitation, statements about our future operating or financial performance, market opportunity, value creation strategy, competition, expected activities in completed and future acquisitions, including statements about the impact of our recently completed acquisition of Magellan Health (the Magellan Acquisition), other recent and future acquisitions and dispositions, investments and the adequacy of our available cash resources. The Company also serves several international markets, and contracts with other healthcare and commercial organizations to provide a variety of specialty services focused on treating the whole person. Centene elevated to the CEO job Sarah London, the company's vice chairman who has held technology [+] and strategy roles with the health insurer, the company said March 22, 2022. Centene.com uses cookies. Her strategic thinking, fresh perspective and diverse experience make her the natural leader to harness the potential of Centene," Centenes Acting Chairman, James Dallas said in a statement. Learn about Centene MISSING VALUE office. . Centene Corporation announced that Sarah London, vice chairman of Centene, has been appointed chief executive officer, effective immediately, succeeding Michael Neidorff. . Sarah London received her BA in Biology and Psychology from Middlebury College and her PhD in Neuroscience from UCLA. Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. Ms. London previously served as Vice President of Client Services & Operations with Humedica, a venture-backed healthcare data and analytics company acquired by Optum in 2013.
Centene Drew Takeover Interest From Cigna in Recent Months Sarah London | Telehealth and Telecare Aware March 22 (Reuters) - U.S. health insurer Centene Corp on Tuesday named Vice Chairman Sarah London as its new chief executive officer, replacing Michael Neidorff, who is on medical leave. ST. LOUIS, March 22, 2022 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Sarah London, Vice Chairman of Centene, has been appointed Chief Executive Officer, effective .
About Centene | Centene Corporation See reviews, salaries & interviews from Centene employees in MISSING VALUE. James Dallas, Centenes acting chairman, said the board sees London as a visionary leader. Spencer Stuart. 396 Ratings.
Sarah London - Executive Bio, Work History, and Contacts - Equilar A copy of the press release announcing the events described in Item 5.02 above
Magna Cum Laude in History & Literature from Harvard College, where she played Division I tennis. Founded in 1984 and headquartered in St. Louis, Missouri, Centene Corporation is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. As the Uvalde community recovers from a tragic shooting, Superior HealthPlan is developing a new community center to serve as a resource for the region.
Sarah London - Biography - MarketScreener To no one's great surprise, the pick is Sarah London, formerly vice chair of the Centene board of directors, one-third of their 'value creation office', and part of the Office of the .
UPDATE 1-Health insurer Centene names Sarah London as new CEO Sarah's mailing address filed with the SEC is 7700, Forsyth Boulevard, Clayton, Saint Louis County, Missouri, 63105, United States. David Westin speaks with top names in finance about the week's biggest issues on Wall Street.
CENTENE APPOINTS SARAH LONDON AS CHIEF EXECUTIVE OFFICER - PR Newswire Rapper, chef and author Action Bronson takes us on a journey from his early days at culinary school, to releasing critically acclaimed albums, to writing books, starring in TV shows and building an iconic brand around his favorite interests. London succeeds Michael Neidorff, who went on medical leave late last month, the company said. I'm excited by the tremendous opportunity to leverage the size and scale of this Company to create true, sustaining value for our members, state partners, employees and shareholders.". Sarah London Age : 42 Public asset : 24,128,130 USD Country of residence : Unknown Linked companies : Centene Corporation Biography of Sarah London Presently, Sarah London is President-Health Care Enterprises at Centene Corp. London takes over a company that is a national player among the biggest names in health insurance, particularly in working with states to manage their Medicaid health insurance for poor Americans and providing individual coverage under the Affordable Care Act.
Executive Leadership | Centene Corporation CNC Company Profile & Executives - Centene Corp. - Wall Street Journal Biography. We have a unique opportunity to empower our members, providers, and their communities in this transformation. Centene Sarah London is the Chief Executive Officer of Centene Corporation, a diversified healthcare enterprise providing a portfolio of government-sponsored healthcare programs focusing on under-insured and uninsured individuals to more than 26 million Americans. Centene ( NYSE: CNC) said it had appointed Sarah London to succeed Michael Neidorff as the Chief . This is the Centene company profile.
Centene Careers and Employment in US | Indeed.com Sarah London leads Centene, a diversified enterprise that has grown to become the leading provider of government-sponsored healthcare, with an established expertise serving lower income and medically complex populations. ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS. Mr. Neidorff remains on a previously announced medical leave of absence from his position on the Board of the Company.
Centene Appoints Sarah London As Chief Executive Officer YEAR. The salaries that employees earn in Centene can be influenced by the department or organization function that they work in. You should not place undue reliance on any forward-looking statements, as actual results may differ materially from projections, estimates, or other forward-looking statements due to a variety of important factors, variables and events including, but not limited to:our ability to accurately predict and effectively manage health benefits and other operating expenses and reserves, including fluctuations in medical utilization rates due to the impact of COVID-19; the risk that the election of new directors, changes in senior management and inability to retain key personnel may create uncertainty or negatively impact our ability to execute quickly and effectively;uncertainty as to the expected financial performance of the combined company following the recent completion of the Magellan Acquisition; the possibility that the expected synergies and value creation from the Magellan Acquisition or the WellCare Acquisition (or other acquired businesses) will not be realized, or will not be realized within the respective expected time periods; the risk that unexpected costs will be incurred in connection with the integration of the Magellan Acquisition or that the integration of Magellan Health will be more difficult or time consuming than expected, or similar risks from other acquisitions we may announce or complete from time to time; disruption from the integration of the Magellan Acquisition or from the integration of the WellCare Acquisition, or similar risks from other acquisitions we may announce or complete from time to time, including potential adverse reactions or changes to business relationships with customers, employees, suppliers or regulators, making it more difficult to maintain business and operational relationships; a downgrade of the credit rating of our indebtedness; competition; membership and revenue declines or unexpected trends; changes in healthcare practices, new technologies, and advances in medicine; increased healthcare costs; changes in economic, political or market conditions; changes in federal or state laws or regulations, including changes with respect to income tax reform or government healthcare programs as well as changes with respect to the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act (collectively referred to as the ACA) and any regulations enacted thereunder that may result from changing political conditions, the new administration or judicial actions; rate cuts or other payment reductions or delays by governmental payors and other risks and uncertainties affecting our government businesses; our ability to adequately price products; tax matters; disasters or major epidemics; changes in expected contract start dates; provider, state, federal, foreign and other contract changes and timing of regulatory approval of contracts; the expiration, suspension, or termination of our contracts with federal or state governments (including, but not limited to, Medicaid, Medicare, TRICARE or other customers); the difficulty of predicting the timing or outcome of legal or regulatory proceedings or matters, including, but not limited to, our ability to resolve claims and/or allegations made by states with regard to past practices, including at Envolve Pharmacy Solutions, Inc. (Envolve), as our pharmacy benefits manager (PBM) subsidiary, within the reserve estimate we have recorded and on other acceptable terms, or at all, or whether additional claims, reviews or investigations relating to our PBM business will be brought by states, the federal government or shareholder litigants, or government investigations; timing and extent of benefits from strategic value creation initiatives, including the possibility that these initiatives will not be successful, or will not be realized within the expected time periods; challenges to our contract awards; cyber-attacks or other privacy or data security incidents; the exertion of management's time and our resources, and other expenses incurred and business changes required in connection with complying with the undertakings in connection with any regulatory, governmental or third party consents or approvals for acquisitions; changes in expected closing dates, estimated purchase price and accretion for acquisitions; the risk that acquired businesses will not be integrated successfully;restrictions and limitations in connection with our indebtedness; our ability to maintain or achieve improvement in the Centers for Medicare and Medicaid Services (CMS) Star ratings and maintain or achieve improvement in other quality scores in each case that can impact revenue and future growth; availability of debt and equity financing, on terms that are favorable to us; inflation; foreign currency fluctuations and risks and uncertainties discussed in the reports that Centene has filed with the Securities and Exchange Commission.